One Man's Reluctant Tour For Adult Stem Cells

Michael Phelan is the CEO of SevOne. My Forbes colleague Tomio Geron recently wrote about his fast-growing IT company and Phelan contributed a guest post earlier this year at Eric Savitz's CIO Network.

Source: Forbes.com Healthcare News - February 21, 2013 Category: Pharmaceuticals Authors: John Farrell Source Type: news